No takes yet. Share an insight, caveat, or question.
Review uncovers the link between metabolic dysfunction-associated steatotic liver disease and liver cancer, suggesting targeted therapies.
Yang et al. (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: